In this episode, Dr. Brandon and Dr. Morgentaler talk about the groundbreaking moments that defined Dr. Morgentaler's career—from challenging long-held medical dogmas about testosterone and prostate cancer to reflecting on courage, science, and the evolving state of modern medicine. 00:00 – Introduction and Lifetime Achievement Award In this episode, Dr. Brandon and Dr. Morgentaler talk about his Lifetime Achievement Award and reflect on the meaning of being recognized by peers after decades in sexual medicine. 03:13 – Early Career and Groundbreaking Research They discuss how Dr. Morgentaler's early curiosity about testosterone—from lizard studies at Harvard to treating men others wouldn't—sparked discoveries that reshaped urology. 08:49 – Challenges and Controversies in Urology Dr. Morgentaler recalls standing firm against public criticism from leading urologists as he presented data that contradicted long-held beliefs about testosterone and cancer. 25:03 – Facing the Hardest Moments in Surgery He opens up about the emotional toll of surgical complications and the weight of caring deeply for patients while maintaining composure under pressure. 28:22 – Breakthroughs in Prostate Cancer Treatment They explore his bold use of testosterone therapy—even for men with advanced cancer—and how it restored vitality and meaning for patients once written off. 36:30 – Challenging Medical Dogma Dr. Morgentaler reflects on why medicine resists new evidence, the persistence of outdated myths, and how progress in science often advances one funeral at a time. Resources: 1. Morgentaler, A., Bruning, C. O., & DeWolf, W. C. (1996). Occult prostate cancer in men with low serum testosterone levels. JAMA, 276(23), 1904–1906. https://doi.org/10.1001/jama.1996.03540230040029 2. Morgentaler, A., & DeWolf, W. C. (1997). Implantation of penile prosthesis at the time of radical prostatectomy: A new approach for erectile rehabilitation. Urology, 49(6), 932–936. https://doi.org/10.1016/S0090-4295(97)00127-4 3. Lincoff, A. M., Nissen, S. E., Krum, H., et al. (2023). Cardiovascular safety of testosterone-replacement therapy. New England Journal of Medicine, 389(6), 514–524. https://doi.org/10.1056/NEJMoa2301761 With Dr. Abraham Morgentaler and Dr. Marianne Brandon Listen to the podcast on all of your favorite platforms: Apple: https://podcasts.apple.com/ec/podcast/the-sex-doctors/id1761813985?l=en-GB Spotify: https://open.spotify.com/show/0apSFzquJXKoOGnmI6ndgT?si=e5a1e482c7ca46c7 Find us on: Instagram: https://www.instagram.com/thesexdoctors?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw== Facebook: https://www.facebook.com/thesexdoctors YouTube: https://www.youtube.com/@thesexdoctorspod TikTok: https://www.tiktok.com/@thesexdoctor LinkedIn (Dr. Abraham): https://www.linkedin.com/in/abraham-morgentaler-md-81628b6 LinkedIn (Dr. Marianne): https://www.linkedin.com/in/mariannebrandon-59224513 X (Dr. Abraham): https://x.com/DrMorgentaler X (Dr. Marianne): https://x.com/drbrandon #ProstateCancerResearch #TestosteroneTherapy #MedicalInnovation

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related